CUMBERLAND PHARMACEUTICALS INC Logo

CUMBERLAND PHARMACEUTICALS INC

Acquires and commercializes branded medicines for acute care, gastroenterology, and oncology.

CPIX | US

Overview

Corporate Details

ISIN(s):
US2307701092
LEI:
Country:
United States of America
Address:
1600 WEST END AVENUE, 37203 NASHVILLE,
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company that acquires, develops, and commercializes a portfolio of branded, FDA-approved prescription medicines. The company is focused on improving patient care by delivering high-quality, innovative products designed to meet specific medical needs. Its commercialized products primarily serve the hospital acute care, gastroenterology, and oncology market segments, providing essential treatments to support medical professionals and their patients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all CUMBERLAND PHARMACEUTICALS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CUMBERLAND PHARMACEUTICALS INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CUMBERLAND PHARMACEUTICALS INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
scPharmaceuticals Inc. Logo
Commercializes subcutaneous drug-device therapies for at-home cardiorenal care.
United States of America SCPH
SCYNEXIS INC Logo
Developing novel anti-fungal therapies for difficult-to-treat, drug-resistant infections.
United States of America SCYX
Seach Medical Group Ltd. Logo
Researches, cultivates, and produces certified medical cannabis oils and flowers for global markets.
Israel SEMG
SEEGENE, INC. Logo
Develops multiplex qPCR diagnostic assays and automated systems for labs and healthcare worldwide.
South Korea 096530
SEIKAGAKU CORPORATION Logo
A research pharma company using glycoscience to develop drugs for orthopedic & ophthalmic diseases.
Japan 4548
SELLAS Life Sciences Group, Inc. Logo
Late-stage biopharma developing novel immunotherapies for a broad range of cancers.
United States of America SLS
Sensei Biotherapeutics, Inc. Logo
Developing tumor-activated biologics to stimulate a targeted immune response against cancer.
United States of America SNSE
Senti Biosciences, Inc. Logo
Developing smart cell and gene therapies with Gene Circuits to precisely target cancer.
United States of America SNTI
SEOUL PHARMA CO.,LTD Logo
Develops pharmaceuticals with innovative Orally Disintegrating Film (ODF) tech for global markets.
South Korea 018680
Septerna, Inc. Logo
Advancing novel small molecule GPCR medicines for endocrine, immune, and metabolic diseases.
United States of America SEPN

Talk to a Data Expert

Have a question? We'll get back to you promptly.